Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free HTGMQ Stock Alerts

HTG Molecular Diagnostics (HTGMQ) Competitors

$0.0001 +0.00 (+∞)
As of 09:30 AM Eastern
Compare

HTGMQ vs. OLITW, PRENW, QSIAW, SMAPW, and TT

Should you buy HTG Molecular Diagnostics stock or one of its competitors? MarketBeat compares HTG Molecular Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HTG Molecular Diagnostics include OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), and Trane Technologies (TT). These companies are all part of the "measuring and control equipment" industry.

How does HTG Molecular Diagnostics compare to OmniLit Acquisition?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and OmniLit Acquisition (NASDAQ:OLITW) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
OmniLit Acquisition N/A N/A N/A

OmniLit Acquisition has lower revenue, but higher earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A
OmniLit AcquisitionN/AN/AN/AN/AN/A

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
OmniLit Acquisition Neutral

Summary

HTG Molecular Diagnostics beats OmniLit Acquisition on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Prenetics Global has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$120.07MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

In the previous week, Prenetics Global had 1 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 1 mentions for Prenetics Global and 0 mentions for HTG Molecular Diagnostics. Prenetics Global's average media sentiment score of 1.87 beat HTG Molecular Diagnostics' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the media.

Company Overall Sentiment
Prenetics Global Very Positive
HTG Molecular Diagnostics Neutral

Summary

Prenetics Global beats HTG Molecular Diagnostics on 3 of the 3 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Quantum-Si?

Quantum-Si (NASDAQ:QSIAW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

In the previous week, Quantum-Si had 1 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 1 mentions for Quantum-Si and 0 mentions for HTG Molecular Diagnostics. Quantum-Si's average media sentiment score of 1.87 beat HTG Molecular Diagnostics' score of 0.00 indicating that Quantum-Si is being referred to more favorably in the media.

Company Overall Sentiment
Quantum-Si Very Positive
HTG Molecular Diagnostics Neutral

Quantum-Si has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quantum-Si$1.85MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Company Net Margins Return on Equity Return on Assets
Quantum-SiN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

Quantum-Si beats HTG Molecular Diagnostics on 2 of the 3 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to SportsMap Tech Acquisition?

SportsMap Tech Acquisition (NASDAQ:SMAPW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
SportsMap Tech AcquisitionN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

SportsMap Tech Acquisition has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SportsMap Tech AcquisitionN/AN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

In the previous week, SportsMap Tech Acquisition's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
SportsMap Tech Acquisition Neutral
HTG Molecular Diagnostics Neutral

Summary

HTG Molecular Diagnostics beats SportsMap Tech Acquisition on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Trane Technologies?

Trane Technologies (NYSE:TT) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Trane Technologies has higher revenue and earnings than HTG Molecular Diagnostics. HTG Molecular Diagnostics is trading at a lower price-to-earnings ratio than Trane Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trane Technologies$21.32B4.88$2.92B$12.9336.44
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

In the previous week, Trane Technologies had 32 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 32 mentions for Trane Technologies and 0 mentions for HTG Molecular Diagnostics. Trane Technologies' average media sentiment score of 1.51 beat HTG Molecular Diagnostics' score of 0.00 indicating that Trane Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Trane Technologies Very Positive
HTG Molecular Diagnostics Neutral

83.0% of Trane Technologies shares are held by institutional investors. 0.4% of Trane Technologies shares are held by company insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Trane Technologies presently has a consensus price target of $509.12, suggesting a potential upside of 8.06%. Given Trane Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Trane Technologies is more favorable than HTG Molecular Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trane Technologies
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
2.68
HTG Molecular Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Trane Technologies has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market. Comparatively, HTG Molecular Diagnostics has a beta of 3.06, meaning that its share price is 206% more volatile than the broader market.

Trane Technologies has a net margin of 13.41% compared to HTG Molecular Diagnostics' net margin of 0.00%. Trane Technologies' return on equity of 35.55% beat HTG Molecular Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Trane Technologies13.41% 35.55% 13.73%
HTG Molecular Diagnostics N/A N/A N/A

Summary

Trane Technologies beats HTG Molecular Diagnostics on 15 of the 17 factors compared between the two stocks.

Get HTG Molecular Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

Export
MetricHTG Molecular DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2K$6.50B$12.37B
Dividend YieldN/AN/A2.67%5.66%
P/E Ratio0.00N/A24.0124.71
Price / Sales0.000.00540.55165.59
Price / CashN/AN/A27.4837.92
Price / BookN/A0.0110.556.85
Net Income-$21.59M-$47.72M$3.56B$337.45M

HTG Molecular Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTGMQ
HTG Molecular Diagnostics
N/A$0.00
+∞		N/AN/A$0.00$6.37MN/A90
OLITW
OmniLit Acquisition
N/A$1.67
flat		N/AN/A$0.00N/AN/A3
PRENW
Prenetics Global
N/A$0.02
flat		N/AN/A$0.00$92.39MN/A1
QSIAW
Quantum-Si
N/A$0.00
-94.8%		N/AN/A$0.00$1.85MN/A150
SMAPW
SportsMap Tech Acquisition
N/A$0.03
+3.5%		N/A-70.0%$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HTGMQ) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel